Occam Recruits Sapna Srivastava to the Board of Nuvalent
Nuvalent, an F-Prime/Deerfield investment, develops innovative small molecules with exquisite target selectivity to overcome resistance, minimize adverse events and drive more durable responses. The company went public in 2021 generating $166M.
In late 2021, Occam recruited Sapna Srivastava, PhD to the Board of Nuvalent. Sapna began her career as an equity analyst on Wall Street before taking on operating CFO roles at innovative biotechs like eGenesis, VelosBio, and Intellia.
Recent Placements
Occam Global is a leading executive search and advisory partner for entrepreneurs, investors, and corporations targeting exceptional goals across the life sciences, deep tech, and venture capital sectors worldwide. Since 2012, Occam has collaborated with top founders, CEOs, and investors across the tech industry to provide high-performing leaders who fuel growth. From stealth startups to public markets, we recruit senior executives, advise on organizational strategies, and invest alongside visionary teams to build innovative companies. Occam’s success is rooted in our proven ability to attract outstanding business and scientific leaders, seamless access to rare talent, and a strong commitment to results guided by high ethics and enlightened aggression. Whether you’re launching, leading, or investing, we are here to support growth through the power of talent.